Elden Ring
Latest about Elden Ring
Sony is officially the largest shareholder of FromSoftware owner Kadokawa
By Demi Williams published
Sony has announced it is now the majority shareholder of FromSoftware owner Kadokawa.
Yes, Elden Ring: Nightreign will feature a "small number" of enemies from the Dark Souls series, director confirms
By Demi Williams published
FromSoftware has confirmed Elden Ring: Nightreign will feature enemies from Dark Souls.
Elden Ring Nightreign brings a standalone co-op roguelite experience to the Lands Between and... hang on a minute, did I just see the Nameless King?
By Rhys Wood published
Elden Ring Nightreign is a standalone co-op game that looks like a mish mash of FromSoftware's greatest hits.
Sony confirms its intention to acquire FromSoftware parent company Kadokawa, but one analyst says the publisher could 'lose its independence' if the deal goes through
By Demi Williams published
Sony has confirmed its interest in acquiring FromSoftware's parent company Kadokawa Group.
One of my favorite Xbox controllers and its glorious Elden Ring special edition are cheaper than they've ever been this Black Friday
By Rhys Wood published
The Thrustmaster eSwap X2 and its stunning Elden Ring special edition just got their first ever Black Friday Xbox controller deal.
Sony is reportedly in talks to acquire Kadokawa, the owner of Elden Ring, Dark Souls, and Bloodborne developer FromSoftware
By Demi Williams published
Sony is reportedly in talks to acquire Kadokawa, the owner of FromSoftware.
Elden Ring crossplay: is there cross-platform multiplayer?
By Patrick Dane last updated
Guide Is there any hope for an Elden Ring crossplay function that would allow a cross-platform PvP experience? This is what you need to know if it sounds like something you need.
Elden Ring patch 1.14 makes Shadow of the Erdtree's final boss easier
By Demi Williams published
Promised Consort Radahn has been nerfed
Get daily insight, inspiration and deals in your inbox
Sign up for breaking news, reviews, opinion, top tech deals, and more.